CTRI/2023/06/053361已完成Unknown
A randomized, single-dose, double-blind, multi-sequence crossover, study to assess the bioavailability of free curcumin in various curcumin formulations in comparison with standard curcumin in health volunteers.
incy Benzy Joshua0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects who are willing to give their written informed consent and comply with the protocol requirements.
- •2.Females of child bearing age, agree to use approved birth control methods during the study, and have negative urine pregnancy test (UPT) at screening.
- •3.Subject understands the study procedures, is ready to comply and provide signed informed consent form (ICF) to participate in the study
排除标准
- •1.Subjects who have consumed curcumin containing food 2 days prior to screening
- •2.Subjects having symptoms of viral infections
- •3.Pregnant or lactating women.
- •4.Subjects with known hypersensitivity to the investigational products.
- •5.Subjects who have participated in any clinical trial in the past 1 month.
- •6.Any subjects found to have entered in to the study in violation of this protocol or if the subject is uncooperative during the study.
- •7.Any other condition that in the opinion of the investigator that does not justify the subject’s participation in the trial.
研究者
相似试验
已完成
1 期
A phase I biosimilar study to compare the pharmacokinetics, Pharmacodynamics, safety and tolerability of BP14 (Pegfilgrastim) with EU-approved Neulasta® in healthy male adult volunteers following a subcutaneous (SC- under the skin) injection.Chemotherapy-induced-neutropeniaCancer - Any cancerBlood - Haematological diseasesACTRN12620000657921CURATEQ BIOLOGICS PRIVATE LIMITED124
已完成
3 期
To compare the clinical efficacy and safety of shilpa adalimumab with Humaria in patients with active Rheumatoid arthritis.CTRI/2021/07/034531Shilpa Biologicals Private Limited201
已完成
不适用
A two-part, single dose, randomized, single-blinded, placebo controlled, phase I study to assess the safety and pharmacokinetics of oral MT1980 in healthy volunteers when dosed in the fasted stateNL-OMON51342Monument Therapeutics Limited26
尚未招募
不适用
A comparative Bioavailability study of BAE20 in Healthy VolunteersCTRI/2020/07/026909Akay Natural Ingredients Pvt Ltd
尚未招募
不适用
A comparative pharmacokinetic study of AryoGen Pharmedâ??s AryoTrust (Trastuzumab) and â??HERCEPTINâ?? (Trastuzumab) in healthy, adult, male subjectsCTRI/2019/03/018218AryoGen Pharmed
